Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active, Moderate to Severe Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00754572
What this trial is testing

Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 418
Testing effectiveness (Phase 2)Active Not RecruitingNCT07233655
What this trial is testing

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Large-scale testing (Phase 3)Study completedNCT03522415
What this trial is testing

Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Moderately to Severely Active Rheumatoid Arthritis
Shanghai Henlius Biotech 275
Testing effectiveness (Phase 2)Study completedNCT00642629
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes

Who this might be right for
Active, Moderate to Severe Rheumatoid Arthritis
Synta Pharmaceuticals Corp. 35
Large-scale testing (Phase 3)Study completedNCT00106522
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 499
Not applicableStudy completedNCT02608112
What this trial is testing

Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Large-scale testing (Phase 3)Study completedNCT02265705
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 290
Early research (Phase 1)Study completedNCT02717988
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Oscotec Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01894516
What this trial is testing

Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 287
Large-scale testing (Phase 3)Study completedNCT04134728
What this trial is testing

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 550
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Large-scale testing (Phase 3)Study completedNCT01721044
What this trial is testing

A Moderate to Severe Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 527
Not applicableStudy completedNCT01375478
What this trial is testing

An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 197
Testing effectiveness (Phase 2)Study completedNCT01404585
What this trial is testing

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 123
Post-approval studies (Phase 4)Study completedNCT03449758
What this trial is testing

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 84
Large-scale testing (Phase 3)Study completedNCT00531817
What this trial is testing

Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 619
Large-scale testing (Phase 3)UnknownNCT04312815
What this trial is testing

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

Who this might be right for
Rheumatoid Arthritis(RA)
SinoMab BioScience Ltd 510
Large-scale testing (Phase 3)Study completedNCT02760368
What this trial is testing

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 428
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Next Page